This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov | 592 |
antiviral | activity | 332 |
- | cell | 143 |
infected | cells | 104 |
viral | replication | 103 |
inhibitory | effect | 96 |
viral | rna | 86 |
antiviral | effect | 69 |
viral | infection | 69 |
- | infection | 68 |
antiviral | drugs | 65 |
inhibitory | effects | 65 |
inhibitory | activity | 55 |
viral | infections | 50 |
- | sars | 48 |
- | influenza | 45 |
antiviral | effects | 42 |
- | protein | 38 |
antiviral | drug | 36 |
- | rna | 33 |
dependent | rna | 33 |
respiratory | viruses | 33 |
novel | coronavirus | 31 |
humans | . | 29 |
respiratory | infections | 28 |
viral | protein | 28 |
antiviral | activities | 28 |
human | coronavirus | 28 |
antiviral | compounds | 28 |
viral | proteins | 27 |
- | coronavirus | 26 |
infectious | virus | 26 |
cellular | proteins | 25 |
infected | mice | 25 |
different | concentrations | 24 |
other | viruses | 24 |
- | activity | 23 |
effective | concentration | 21 |
- | cells | 21 |
- | treatment | 21 |
human | cells | 18 |
- | mouse | 17 |
clinical | studies | 17 |
- | drug | 15 |
- | virus | 15 |
active | compounds | 15 |
specific | antibodies | 14 |
specific | inhibitors | 14 |
inhibitory | concentration | 14 |
several | studies | 14 |
- | peptide | 14 |
human | influenza | 13 |
respiratory | virus | 13 |
therapeutic | effect | 13 |
antiviral | compound | 12 |
inhibitory | activities | 12 |
significant | . | 12 |
effective | concentrations | 10 |
respiratory | coronavirus | 10 |
other | proteins | 10 |
antivirals | . | 10 |
antiviral | treatment | 10 |
antiviral | assays | 10 |
human | infection | 9 |
therapeutic | effects | 9 |
high | concentration | 8 |
other | groups | 8 |
viral | activity | 8 |
significant | effect | 7 |
therapeutics | . | 7 |
inhibitory | concentrations | 7 |
dependent | . | 7 |
antiviral | studies | 7 |
different | viruses | 7 |
novel | sars | 6 |
novel | inhibitors | 6 |
viral | peptides | 6 |
therapeutic | drug | 6 |
several | viruses | 6 |
new | coronavirus | 6 |
immune | cells | 6 |
human | viruses | 6 |
effective | . | 6 |
cellular | protein | 6 |
acute | infection | 6 |
- | inhibitor | 6 |
other | studies | 5 |
other | coronavirus | 5 |
other | rna | 5 |
novel | activities | 5 |
specific | inhibitor | 5 |
therapeutic | treatment | 5 |
therapeutic | treatments | 5 |
other | compounds | 5 |
different | rna | 5 |
new | drug | 5 |
different | groups | 5 |
cellular | rna | 5 |
different | cell | 5 |
human | cell | 5 |
antiviral | protein | 5 |
effective | inhibitor | 5 |
different | treatment | 5 |
low | . | 4 |
viral | drugs | 4 |
specific | treatment | 4 |
specific | effects | 4 |
specific | activity | 4 |
several | compounds | 4 |
other | cell | 4 |
new | drugs | 4 |
lower | concentration | 4 |
severe | influenza | 4 |
infected | cell | 4 |
high | antibody | 4 |
immune | mouse | 4 |
antiviral | treatments | 4 |
effective | treatment | 4 |
high | . | 4 |
new | treatment | 4 |
higher | concentration | 4 |
highest | concentrations | 4 |
human | infections | 4 |
highest | concentration | 4 |
other | virus | 3 |
new | compounds | 3 |
new | infections | 3 |
novel | drugs | 3 |
novel | inhibitor | 3 |
other | drugs | 3 |
specific | . | 3 |
several | cell | 3 |
specific | antibody | 3 |
specific | rna | 3 |
specific | treatments | 3 |
such | drug | 3 |
low | concentrations | 3 |
such | compounds | 3 |
immune | cell | 3 |
infectious | viruses | 3 |
antiviral | inhibitor | 3 |
human | . | 3 |
active | compound | 3 |
active | virus | 3 |
acute | virus | 3 |
antiviral | concentrations | 3 |
- | day | 3 |
antiviral | peptide | 3 |
high | concentrations | 3 |
different | . | 3 |
different | concentration | 3 |
effective | compounds | 3 |
antiviral | peptides | 3 |
several | rna | 2 |
several | drugs | 2 |
respiratory | rna | 2 |
respiratory | influenza | 2 |
other | sars | 2 |
new | mouse | 2 |
other | . | 2 |
novel | compounds | 2 |
new | influenza | 2 |
lower | concentrations | 2 |
lower | . | 2 |
similar | . | 2 |
significant | activity | 2 |
such | studies | 2 |
low | concentration | 2 |
similar | concentration | 2 |
specific | compounds | 2 |
specific | drugs | 2 |
specific | peptide | 2 |
specific | protein | 2 |
viral | activities | 2 |
viral | assays | 2 |
viral | cell | 2 |
viral | compounds | 2 |
viral | effect | 2 |
viral | effects | 2 |
low | virus | 2 |
different | compound | 2 |
low | activity | 2 |
dependent | protein | 2 |
inhibitory | peptides | 2 |
- | al | 2 |
- | effects | 2 |
- | infections | 2 |
- | peptides | 2 |
- | proteins | 2 |
antiviral | assay | 2 |
antiviral | inhibitors | 2 |
clinical | effects | 2 |
clinical | study | 2 |
dependent | effect | 2 |
active | inhibitors | 2 |
different | drug | 2 |
human | antibody | 2 |
inhibitory | peptide | 2 |
different | virus | 2 |
inhibitory | assay | 2 |
immune | antibodies | 2 |
human | sars | 2 |
human | virus | 2 |
higher | drug | 2 |
higher | concentrations | 2 |
effective | inhibitors | 2 |
effective | influenza | 2 |
other | assays | 1 |
other | protein | 1 |
other | effects | 1 |
other | group | 1 |
other | infections | 1 |
other | mice | 1 |
several | days | 1 |
other | treatments | 1 |
others | . | 1 |
others | peptide | 1 |
respiratory | infection | 1 |
several | mouse | 1 |
novel | viruses | 1 |
other | antibodies | 1 |
low | et | 1 |
novel | treatment | 1 |
novel | mouse | 1 |
novel | drug | 1 |
novel | antibody | 1 |
new | virus | 1 |
new | sars | 1 |
lowest | concentrations | 1 |
lowest | . | 1 |
lower | virus | 1 |
lower | activity | 1 |
low | replication | 1 |
several | virus | 1 |
low | effect | 1 |
several | proteins | 1 |
similar | studies | 1 |
severe | infection | 1 |
specific | effect | 1 |
viral | concentrations | 1 |
viral | concentration | 1 |
viral | assay | 1 |
therapeutics | virus | 1 |
therapeutic | drugs | 1 |
therapeutic | activity | 1 |
such | treatment | 1 |
such | infections | 1 |
such | effects | 1 |
such | cell | 1 |
such | activity | 1 |
specific | virus | 1 |
specific | peptides | 1 |
specific | cells | 1 |
severe | sars | 1 |
specific | cell | 1 |
similar | viruses | 1 |
infectious | cell | 1 |
similar | rna | 1 |
similar | infection | 1 |
similar | effects | 1 |
similar | effect | 1 |
similar | concentrations | 1 |
similar | compounds | 1 |
similar | activity | 1 |
significant | treatment | 1 |
significant | effects | 1 |
significant | cell | 1 |
low | antibody | 1 |
higher | . | 1 |
infectious | assay | 1 |
active | inhibitor | 1 |
dependent | cell | 1 |
clinical | treatments | 1 |
clinical | treatment | 1 |
clinical | influenza | 1 |
clinical | effect | 1 |
clinical | drug | 1 |
antiviral | study | 1 |
antiviral | rna | 1 |
antiviral | antibody | 1 |
antiviral | . | 1 |
acute | influenza | 1 |
acute | infections | 1 |
active | treatment | 1 |
active | drugs | 1 |
infected | mouse | 1 |
active | drug | 1 |
active | cells | 1 |
active | . | 1 |
- | study | 1 |
- | replication | 1 |
- | mice | 1 |
- | inhibitors | 1 |
- | h | 1 |
- | effect | 1 |
- | drugs | 1 |
- | compounds | 1 |
- | compound | 1 |
- | antibody | 1 |
dependent | drug | 1 |
dependent | replication | 1 |
different | activities | 1 |
different | assays | 1 |
infected | group | 1 |
immune | activity | 1 |
human | rna | 1 |
human | replication | 1 |
human | cov | 1 |
human | activity | 1 |
higher | replication | 1 |
higher | cell | 1 |
higher | antibody | 1 |
higher | activity | 1 |
high | treatment | 1 |
high | replication | 1 |
high | activity | 1 |
effective | treatments | 1 |
effective | replication | 1 |
effective | drugs | 1 |
effective | drug | 1 |
effective | compound | 1 |
effective | antibodies | 1 |
different | replication | 1 |
different | proteins | 1 |
different | mouse | 1 |
different | inhibitor | 1 |
different | effects | 1 |
different | coronavirus | 1 |
different | compounds | 1 |
different | cells | 1 |
viral | studies | 1 |